Family Medicine Doctors in Wilmore, KY Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Dr. Anthony W Flannery, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Rice St, Wilmore, KY 40390 Phone: 859-858-9355 Fax: 859-858-0416 |
Dr. Thomas Fred Coburn, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Rice St, Wilmore, KY 40390 Phone: 859-858-9355 Fax: 859-858-0416 |
 Dr. Monica Cox Ray, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Macklem Dr, Wilmore, KY 40390 Phone: 859-858-3511 Fax: 859-858-0003 |
John Norwood Chapman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Rice St, Wilmore, KY 40390 Phone: 859-858-9355 Fax: 859-858-0416 |
Dr. Amanda M Vickers, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Rice St, Wilmore, KY 40390 Phone: 859-858-9355 Fax: 859-858-0416 |
Ernest Thompson O'neal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Bellevue Ave, Wilmore, KY 40390 Phone: 859-858-0609 |
News Archive
Researchers develop and test new prostate cancer screening method
Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.
Researchers find inhibition of basic cellular process that contributes to schizophrenia
Surprisingly little is known about schizophrenia. It was only recognized as a medical condition in the past few decades, and its exact causes remain unclear. Since there is no objective test for schizophrenia, its diagnosis is based on an assortment of reported symptoms.
DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results
DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.
Europe should adopt WHO recommendations for particulate matter cuts
Europe must adopt the World Health Organization (WHO) standard on fine particulate matter pollution if it is to significantly curb needless premature deaths, concludes research in the Journal of Epidemiology and Community Health.
Asbestos related cancer risk rises after home renovations: Study
A third wave of asbestos-related cancers is emerging as the rate of malignant mesothelioma caused by exposure to asbestos during home renovations increases dramatically, according to new research.
› Verified 1 days ago